🇪🇺EU · EMAWithdrawnATC: J07BB03

Fluenz(reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain)

Influenza, Human;Immunization

Marketing Authorisation Holder: MedImmune LLC

EMA Authorisation: 27/01/2011

INN: influenza vaccine (live attenuated, nasal)

Indication

Prophylaxis of influenza in individuals 24 months to less than 18 years of age. The use of Fluenz should be based on official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fluenz — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Fluenz Create Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.